Pharmacological agents for the treatment of urinary incontinence due to overactive bladder

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.1, 2001-01, pp. : 65-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review

By Abramov Yoram Sand Peter K

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2351-2359

Informa Healthcare

Access to resources Recommend Favorite

Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence

By Sacco Emilio Bientinesi Riccardo Tienforti Daniele Racioppi Marco Gulino Gaetano D'Agostino Daniele Vittori Matteo Bassi Pierfrancesco

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 433-448

Informa Healthcare

Access to resources Recommend Favorite

Improving the Tolerability of Anticholinergic Agents in the Treatment of Overactive Bladder

By Dmochowski Roger

Drug Safety, Vol. 28, Iss. 7, 2005-01 ,pp. : 583-600

Adis International

Access to resources Recommend Favorite

Clinical Burden and Nonpharmacologic Management of Nursing Facility Residents with Overactive Bladder and/or Urinary Incontinence

By ZarowitzBarbara J.Omnicare Inc. Cincinnati Ohio USA AllenCarrie O'SheaTerrence TangalosEric BernerTodd OuslanderJoseph G.

The Consultant Pharmacist, Vol. 30, Iss. 9, 2015-09 ,pp. : 533-542

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder

By Oefelein Michael G.

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 733-754

Adis International

Access to resources Recommend Favorite